statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Jefferies slashes Alkem Labs' target price despite surge in Q4 profits, sees 20% downside

Alkem Laboratories' guidance of FY25 revenue growth at 10 percent is under Jefferies' estimates.

US FDA releases details of observations on Alkem's Baddi Plant

The US FDA had conducted an inspection of the facility last month and had made ten procedural observations, including issues with cleanliness and the company's failure to keep written documents on quality control procedures.

Indian pharmaceutical market registers 9.5% growth in March

While most of the corporates have shown double digit value growth, unit growth remains a challenge for the Indian pharma market, according to analysts

Alkem Laboratories sinks 3 percent on US FDA's 10 observations for Himachal unit

After the US FDA inspection, Alkem Laboratories has received Form 483 with 10 observations for its Baddi plant.

Diabetes, BP drugs to cost less as NPPA fixes retail prices of 69 formulations

Various drugs manufactured by listed players like Sun Pharmaceuticals, Alkem Laboratories, Cipla Ltd, Mankind Pharma, Lupin Ltda and Torrent Pharma are included in the list.

Sun Pharma, Lupin, Alkem recall products from US market

Sun Pharma is recalling 54,960 bottles of Mesalamine Extended-Release Capsules, an anti-inflammatory medicine used to treat a type of bowel disease known as ulcerative colitis

Neutral Alkem; target of Rs 5160: Motilal Oswal

Motilal Oswal recommended Neutral rating on Alkem with a target price of Rs 5160 in its research report dated February 21, 2024.

Alkem Labs reports 'fraudulent transfer' of Rs 52 crore from cyber-security breach

The company had hired an external agency to investigate the matter

Alkem Labs hits 52-week high on sell of US facility to New Mill Capital Holdings

The company received total consideration of USD 7,960,000.

Alkem Laboratories Ltd. engages in the development, manufacture, and sale of pharmaceutical products. It produces branded generics, generic drugs, active pharmaceutical ingredient, and nutraceuticals. The company was founded by Samprada Singh and Basudeo Narain Singh on August 8, 1973 and is headquartered in Mumbai, India.

Volume	171,272.00
52-Wk High	5,578.80
52-Wk Low	3,447.00

ALKEM.NSE Alkem Laboratories Limited

About

Feed

News

Sentiment

Fundamentals